Hypercholesterolemia vs CKD
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Hypercholesterolemia
Read full descriptionHide full description
@Point of Care™ with Cognitive AI is a clinical decision-making mobile platform. Hypercholesterolemia @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hypercholesterolemia @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Hypercholesterolemia content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
CKD
This app assists healthcare professionals in discussing new or potential Chronic Kidney Disease (CKD) diagnoses with patients. It provides guidance for navigating these sensitive conversations effectively.
- Patient conversation guidance
- CKD diagnosis support
- Clinician tool
- Risk assessment assistance
Read full descriptionHide full description
A guide to help clinicians navigate a potentially difficult conversation with patients who have a new or at risk for a CKD diagnosis.
Screenshots
Verdict
The clearest difference is update cadence: Hypercholesterolemia at every 2 months against CKD's every 5 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Hypercholesterolemia ships an update every 2 months, CKD every 5 months. The most recent releases landed on September 18, 2026 and June 24, 2026 respectively.
| Parameter | Hypercholesterolemia | CKD |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | Every 2 months — better | Every 5 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.0 | 13.0 — better |
| Further details — not scored | ||
| Size | 21 MB | 48 MB |
| Age rating | 12+ | 12+ |
| Developer | @Point of Care | Island Peer Review Organization, Inc |
In-app purchases
Hypercholesterolemia
No in-app purchases
CKD
No in-app purchases








